Skip to main content
Clinical Trials/NL-OMON44207
NL-OMON44207
Withdrawn
Not Applicable

Tight control in the vascular endotype of systemic sclerosis. Improving outcomes in pulmonary arterial hypertension associated with systemic sclerosis using personalized medicine, a predictive study. - Tight control in the vascular endotype of systemic sclerosis.

Radboudumc0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
pulmonale hypertensie
Sponsor
Radboudumc
Enrollment
50
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Radboudumc

Eligibility Criteria

Inclusion Criteria

  • Fulfilling the ACR\-Eular classification criteria of systemic sclerosis (15\)
  • DLCO \<80% of predicted
  • Age over 18 years

Exclusion Criteria

  • Diagnosis of pulmonary hypertension
  • Current treatment with endothelin receptor antagonists or angiotensin blokkers
  • Cyclophosphamide treatment or autologous stem cell transplantation

Outcomes

Primary Outcomes

Not specified

Similar Trials